Category: Biography

🎓 Education

Dr. Constantin-Ioan Busuioc’s educational journey exemplifies dedication to academic excellence in medicine. He completed his Medical Doctor (M.D.) degree at the University of Medicine and Pharmacy “Iuliu Haţieganu” in Cluj-Napoca, Romania (2005–2011) 🩺. Subsequently, he pursued a Ph.D. at the same institution from 2015 to 2022, delving into molecular and immunohistochemical aspects of malignancies, particularly colorectal adenocarcinoma. His rigorous research training culminated in several significant publications and conference presentations. In 2021, he obtained a Certificate in Health Services Management from the National School of Public Health, Management and Training, enhancing his administrative and healthcare policy knowledge 📊. Additionally, he undertook a fellowship in Hematopathology at the prestigious European Institute of Oncology in Milan, Italy, under Prof. Dr. Stefano A. Pileri. This diverse academic path has equipped him with a well-rounded perspective, blending clinical pathology, biomedical research, and health systems management. 📚🧠

🏥 Experience

With over a decade of professional experience, Dr. Busuioc has held key pathology roles across several European institutions. His current role at Saint Mary Clinical Hospital (since 2023) involves high-stakes diagnostics, intraoperative evaluations, and necropsies. From 2021 to 2023, he served at the National Institute of Infectious Diseases “Prof. Dr. Matei Balș”, specializing in infectious pathology, autopsies, and immunohistochemistry. 🧫 Earlier roles include long-term service at Oncoteam Diagnostic and previous tenure at Synevo, where he managed complex diagnostic cases involving general and hematopathology. Internationally, he worked as Chef de Clinique at Valais Hospital in Switzerland (2018–2019) and completed an intensive fellowship at the European Institute of Oncology, Italy. His foundational years were spent as a resident at Cluj-Napoca County Hospital, with rotations at specialized hospitals including the Oncology Institute and Gastroenterology Institute. His vast experience shapes his precision in diagnosis and depth in pathology. 🧬🦠

🧠 Research Interests

Dr. Busuioc’s research interests lie at the intersection of molecular oncology, immunohistochemistry, and epithelial-mesenchymal transition (EMT) in gastrointestinal malignancies, particularly colorectal and esophageal cancers. He is also intrigued by gene expression profiling, diagnostic biomarkers, and tumor microenvironment interactions. 🧬 His studies often explore the role of EMT markers like Vimentin and E-cadherin in predicting tumor progression. Utilizing bioinformatics tools, he analyzes molecular pathways and gene signatures such as MMP3 and TESC, aiming to enhance early detection and personalized treatment approaches. He has contributed significantly to the understanding of PD-L1 expression, particularly in esophageal carcinoma, and its immunological implications. Additionally, he has co-authored studies on rare case presentations such as Kikuchi-Fujimoto disease and lymphomas in gynecological tissues. His collaborative approach and interdisciplinary mindset make his research impactful and translational. 🔍🧫

🏆 Awards

Dr. Constantin-Ioan Busuioc has earned recognition for his commitment to excellence in pathology and oncology research. One of the highlights of his academic career is being part of the UEFISCDI-awarded article published in Cancers (Basel), which offered a comprehensive review of MAPK pathways as therapeutic targets in cancer. 🏅 His insightful contributions to colorectal cancer pathology and bioinformatics analysis have garnered attention in Romanian medical circles and abroad. His consistent publication in high-impact journals reflects a commendable academic rigor. He has also been nominated for multiple academic awards through Romanian and European research forums. His interdisciplinary case studies, particularly in complex co-morbidities, showcase his versatility as both a clinician and a researcher. These recognitions not only validate his scientific acumen but also reinforce his status as a dedicated and innovative medical professional. 🌟📖

📚Top Noted Publications

Dr. Busuioc has co-authored 12+ peer-reviewed articles in reputable international journals, reflecting his impactful work in pathology and molecular oncology:

Aberrant Immunohistochemical Expression in Colorectal Adenocarcinoma
Chirurgia (Bucur), 2022
- Focus: Aberrant IHC patterns in colorectal cancer
- Citations: 5
- Notes: Highlights novel expression markers potentially linked to prognosis and therapy responsiveness.
MMP3 & TESC in Colon Adenocarcinoma
BioMedInformatics, 2022
- Focus: Role of MMP3 and TESC genes in colon cancer progression using computational biology tools
- Citations: 2
EMT Gene Signature & Prognosis in Colon Adenocarcinoma
Journal of Personalized Medicine, 2021
- Focus: EMT-related gene expression linked to prognosis and patient stratification
- Citations: 10
- Impact: Widely referenced in personalized therapy literature.
PD-L1 Expression in Esophageal Carcinomas
Chirurgia (Bucur), 2022
- Focus: PD-L1 immunostaining in esophageal cancer subtypes
- Notes: Adds data to the ongoing debate on immunotherapy eligibility.
MAPK Pathways Review: Biological Mechanisms & Therapeutic Targets in Oncology
Cancers (Basel), 2019
- Focus: Comprehensive review of MAPK signaling in cancer
- Citations: 100+
- Recognition: Award-winning article, highly cited in targeted therapy discussions.
Multidisciplinary Team in Rectal Cancer Management: Integration & Outcomes
Clujul Med, 2017
- Focus: Clinical coordination in colorectal cancer treatment
- Notes: Addresses practical framework for collaborative cancer care.

🩺 Internal Medicine, Autoimmunity & Rare Conditions

Case of Acute Polyarthritis with Severe Comorbidity
Internal Medicine, 2021
- Focus: Complex internal medicine case with overlapping rheumatological and systemic features
Sarcoidosis Associated with Solid Pseudopapillary Tumor: A Diagnostic Rarity
Romanian Journal of Internal Medicine, 2022
- Focus: Uncommon tumor presentation in a patient with sarcoidosis
Episcleritis in Granulomatosis with Polyangiitis: A Diagnostic Challenge
Romanian Journal of Ophthalmology, 2021
- Focus: Ocular manifestation of a systemic vasculitis
Kikuchi-Fujimoto Disease Mimicking Systemic Lupus Erythematosus
Romanian Journal of Rhinology, 2022
- Focus: Autoimmune overlap and diagnostic pitfalls
Primary Gynecological Lymphomas: A Behavioural Case Perspective
Annals of Behavioural Science, 2018
- Focus: Behavioral and clinical aspects of gynecological lymphoma diagnosis and management

Conclusion

Dr. Constantin-Ioan Busuioc is a strong candidate for a Best Researcher Award, especially in the field of oncopathology, molecular diagnostics, and histopathology. His blend of clinical practice, interdisciplinary research, and international experience makes him highly competitive. With enhanced visibility in research leadership roles and international scholarly forums, his profile would be further elevated to a global best researcher standard.

King-cheong LAM | Molecular Biology | Best Researcher Award

Posted on 11/04/202511/04/2025 by sciencefather

Dr. King-cheong LAM | Molecular Biology | Best Researcher Award

Senior Lecturer, at The School of Professional Education and Executive Development (SPEED), The Hong Kong Polytechnic University, Hong Kong.

Dr. LAM King-cheong Antony is a seasoned academic currently serving as a Senior Lecturer in the Division of Science, Engineering and Health Studies at the College of Professional and Continuing Education (CPCE), The Hong Kong Polytechnic University. With a rich interdisciplinary background in physics and engineering education, Dr. Lam has consistently contributed to innovative teaching methods and research initiatives. His career journey from a secondary school teacher to a respected university lecturer is marked by dedication to student development, academic leadership, and community outreach. 📘 His roles as Programme Leader and Co-Investigator in prestigious funded projects reflect his commitment to applied research and educational advancement. Through his work in nanotechnology, sustainable energy, and smart sensor systems, Dr. Lam exemplifies a professional devoted to shaping the future of science education and technology for sustainable urban living. 🌱

Professional Profile

🎓 Education

Dr. Antony Lam’s academic path is built on a solid foundation in science and education. 🎓 He earned his Doctor of Philosophy from The Hong Kong Polytechnic University in 2017, where he focused on gas sensing materials using graphene-based composites. Prior to that, he completed his Master of Philosophy (2008) and Bachelor of Science in Physics (2005) at The University of Hong Kong, establishing his grounding in physical sciences. Recognizing the importance of pedagogy in science, he also pursued a Postgraduate Diploma in Education from The University of Hong Kong in 2010, equipping himself with the skills to bridge research and teaching. This rare blend of scientific rigor and educational expertise empowers him to mentor students and lead cross-disciplinary research with confidence. 🧠 His training has laid the foundation for a career devoted to both scientific discovery and academic development.

💼 Experience

Dr. Lam’s professional career spans across secondary and tertiary education sectors. 🏫 From 2007 to 2012, he began his journey as a science teacher at Heung To Secondary School (TKO), where he nurtured young minds with enthusiasm for physics. In 2018, he transitioned to higher education as a Lecturer at CPCE, The Hong Kong Polytechnic University, and was promoted to Senior Lecturer in 2024. Over the years, Dr. Lam has taken on several key academic leadership roles, including Programme Leader for Associate in Engineering and Higher Diploma in Aircraft Services Engineering, and Assistant Programme Leader for the BEng (Hons) in Mechanical Engineering. 💼 These positions not only reflect his pedagogical expertise but also his capability in curriculum innovation and academic governance. Dr. Lam’s dedication to bridging practical engineering with academic training is central to his career mission of advancing applied science education. ⚙️

🔬 Research Interests

Dr. Lam’s research interests lie at the intersection of nanotechnology, green energy, sustainable materials, and smart sensing systems. 🌍 His work explores the fabrication of advanced materials such as tin-based perovskites, graphene composites, and aluminum-ion batteries to enhance energy efficiency and sensor capabilities. A significant part of his research addresses real-world sustainability challenges—ranging from developing natural fiber/concrete composites for eco-friendly buildings to ionic-liquid-based gas sensors for smart cities. 🏙️ He is also actively investigating thermal and mechanical properties of biomaterials, including mycelium-based composites for biomedical applications. His interdisciplinary approach combines physics, chemistry, and engineering to produce applicable technologies for energy and healthcare sectors. Through multiple funded projects and international conferences, Dr. Lam has established himself as a researcher committed to translational science for societal impact. 🌱

🏅 Awards

Dr. Lam’s research excellence has earned him both institutional recognition and competitive external grants. 🏆 In 2023, he received the KML Third Prize (HK$200,000) from the Koo Meng Li and Koo Mi Wen Na Charitable Foundation Limited for his project on natural fiber/concrete composites for sustainable buildings. He has been a Principal Investigator and Co-Investigator in numerous high-impact projects, including a nearly HK$1 million RGC-funded project on mycelium-based insoles for diabetic care. 💰 These awards and grants highlight his innovative work in sustainable technology and material science. Dr. Lam’s recognition not only reflects his technical acumen but also his leadership in building collaborative, real-world solutions. His consistent involvement in cutting-edge research underscores his role as a forward-thinking academic in science and engineering education. 🧪

📚 Top Noted Publications

Dr. Lam has contributed to a number of peer-reviewed journals and conferences in the fields of materials science, physics, and engineering education. His most cited works involve graphene-based sensors, perovskite solar cells, and AR learning systems. 📖 His publication list includes:

1. Ahmed, S. B., Kan, H. W., Lam, K. C., & Yip, C. T. (2025)

Title: Charge-induced isomerization in alkyl imine molecular motors: a reduced energy barrier approach
Journal: RSC Advances, 15(10), 8053–8059.

Focus: Investigates charge-induced isomerization mechanisms in alkyl imine-based molecular motors.
Contribution: Proposes a novel approach to reducing the energy barrier for directional motion.
Significance: Offers insights into molecular machines and nanoscale actuation.

2. Wang, Y. D., et al., incl. Lam, K. C. (2024)

Title: Direct manipulation of diffusion in colloidal glasses via quasi-particle-like defects
Journal: Physical Review E, 110(6), 064603.

Focus: Explores defect-driven dynamics in colloidal glasses.
Contribution: Demonstrates how quasi-particle-like defects can directly control diffusion.
Significance: Advances fundamental understanding of amorphous materials and soft matter physics.

3. Li, K. C., Lam, K. C., et al. (2024)

Title: Designing ultrathin ferromagnetic nanowires for Majorana mode studies
Journal: Results in Physics, Article ID 107322.

Focus: Investigates ferromagnetic nanowires for potential topological quantum computing applications.
Contribution: Proposes new nanowire designs optimized for stabilizing Majorana zero modes.
Significance: Supports progress in solid-state quantum computation.

4. Lo, K., Ng, J., Chau, & Lam, A. (2023)

Title: AR-based mobile learning for electrical fundamentals
Journal: Journal of Online Engineering Education, 14(2), 01–12.

Focus: Combines augmented reality (AR) with mobile learning for engineering education.
Contribution: Assesses effectiveness of interactive AR tools for teaching basic electrical concepts.
Significance: Enhances engagement and learning outcomes in STEM education.

5. Lam, K. C., Huang, B., & Shi, S. Q. (2017)

Title: Room-temperature methane gas sensing with graphene-SnO₂
Journal: Journal of Materials Chemistry A, 5, 11131–11142.

Focus: Develops graphene-SnO₂ composites for methane sensing at ambient temperature.
Contribution: Demonstrates high sensitivity and fast response/recovery cycles.
Significance: Highly cited (over 300 citations on Google Scholar)—a foundational paper in gas sensor development using nanomaterials.

Conclusion

Dr. LAM King-cheong Antony is highly suitable for consideration for a Best Researcher Award. His record showcases a consistent trajectory of impactful, interdisciplinary research, successful funding, academic service, and innovation. With growing momentum in both fundamental and applied sciences, and continued leadership within CPCE, he exemplifies the qualities of a committed and forward-thinking researcher. Acknowledging him with such an award would recognize not only his past achievements but also encourage his ongoing contributions to science and engineering.

Christo Nanev | Proteomics | Best Researcher Award

Posted on 11/04/202511/04/2025 by sciencefather

Prof. Dr. Christo Nanev | Proteomics | Best Researcher Award

Professor Doctorate, at INST PHYSICAL CHEMISTRY BAS, Bulgaria.

Prof. Christo N. Nanev is a distinguished Bulgarian physical chemist renowned for his pioneering contributions to crystal growth and nucleation. He earned his PhD under the mentorship of Academician Rostislaw Kaischew and later achieved a Doctor of Science degree in Physical Chemistry from the Bulgarian Academy of Sciences. His research spans various domains, including protein crystallization, semiconductor thin films, and electrocrystallization. Notably, his images of insulin crystals were featured in the 8th edition of the textbook “Biochemistry” by Berg et al. Prof. Nanev has authored over 150 scientific papers and holds five patents. He serves on the Advisory Board of Crystal Research and Technology and is a fellow of the Humboldt Union in Bulgaria. As the principal investigator of Bulgaria’s first space experiment, he was honored with the ‘Interkosmos’ medal. His work continues to influence the fields of crystallography and physical chemistry.

Professional Profile

🎓 Education

Prof. Nanev completed his undergraduate studies at the Chemical Faculty of Sofia University “St. Kliment Ohridski” in Bulgaria. During his academic tenure, he specialized in the growth of crystal whiskers at the Institute of Physics, Czechoslovak Academy of Sciences in Prague. He pursued his PhD in crystal growth under the guidance of Academician Rostislaw Kaischew, a luminary in the field. Subsequently, he attained the Doctor of Science degree in Physical Chemistry from the Bulgarian Academy of Sciences, reflecting his profound expertise and contributions to the discipline. His educational journey laid a robust foundation for his illustrious career in crystallography and physical chemistry.

🧪 Experience

With a career spanning several decades, Prof. Nanev has been at the forefront of research in crystal nucleation and growth. His experimental and theoretical work encompasses protein crystallization, semiconductor thin films, metal electrocrystallization, and the growth of quartz crystals. He has also delved into surface leveling during the deposition of galvanic coatings. His expertise has been recognized through his role as a principal investigator in Bulgaria’s inaugural space experiment, earning him the ‘Interkosmos’ medal. Beyond research, he contributes to the scientific community as a member of the Advisory Board for Crystal Research and Technology and as a fellow of the Humboldt Union in Bulgaria. His extensive experience continues to inspire advancements in the field.

🔬 Research Interests

Prof. Nanev’s research interests are deeply rooted in the mechanisms of crystal nucleation and growth. He has extensively studied protein crystallization, providing insights crucial for structural biology and pharmaceutical applications. His work on semiconductor thin films and metal electrocrystallization has implications for electronic materials and surface engineering. Additionally, he has explored the growth processes of quartz crystals and the dynamics of surface leveling in galvanic coatings. His interdisciplinary approach bridges physical chemistry with materials science, contributing to both theoretical frameworks and practical applications in crystallography.

🏅 Awards

Prof. Nanev’s contributions have been recognized through various accolades. Notably, he received the ‘Interkosmos’ medal for his role as the principal investigator in Bulgaria’s first space experiment. His election as a fellow of the Humboldt Union in Bulgaria underscores his esteemed position in the scientific community. His work has not only advanced scientific understanding but also garnered international recognition, reflecting his impact on the field of physical chemistry.

📚 Top Noted Publications

Prof. Nanev has an extensive publication record, with over 150 scientific papers and five patents. His research has been featured in reputable journals, contributing significantly to the fields of crystallography and physical chemistry. Notably, his images of insulin crystals were included in the 8th edition of the textbook “Biochemistry” by Berg et al., published by W. H. Freeman in 2015. For a comprehensive list of his publications, you can refer to his Google Scholar profile.

📌 1. Nucleation of Lysozyme Crystals Under External Electric and Ultrasonic Fields

Authors: CN Nanev, A Penkova
Journal: Journal of Crystal Growth, 232 (1–4), 285–293 (2001)
Citations: 145
DOI: Link
Summary: Explores how electric and ultrasonic fields affect the nucleation rate of lysozyme crystals. Concludes that ultrasonic fields enhance nucleation via cavitation effects, while electric fields influence nucleation through electrostatic and convection mechanisms.

📌 2. Heterogeneous Nucleation (and Adhesion) of Lysozyme Crystals

Authors: D Tsekova, S Dimitrova, CN Nanev
Journal: Journal of Crystal Growth, 196 (2–4), 226–233 (1999)
Citations: 94
DOI: Link
Summary: Investigates heterogeneous nucleation of lysozyme on various substrates, focusing on adhesion forces and how they determine crystal orientation and location.

📌 3. Temperature-Independent Solubility and Interactions Between Apoferritin Monomers and Dimers in Solution

Authors: DN Petsev, BR Thomas, ST Yau, D Tsekova, CN Nanev, WW Wilson, et al.
Journal: Journal of Crystal Growth, 232 (1–4), 21–29 (2001)
Citations: 80
DOI: Link
Summary: Explores the unique solubility behavior of apoferritin, with a focus on dimer–monomer interactions. Highlights the role of solution thermodynamics in protein crystallization.

📌 4. Protein Crystal Nucleation in Pores

Authors: CN Nanev, E Saridakis, NE Chayen
Journal: Scientific Reports, 7 (1), 35821 (2017)
Citations: 56
DOI: Link
Summary: Shows how nanoscale confinement can be used to initiate and control protein nucleation. Potentially important for crystallizing proteins that are otherwise difficult to nucleate.

📌 5. Kinetics of Insulin Crystal Nucleation, Energy Barrier, and Nucleus Size

Authors: CN Nanev, FV Hodzhaoglu, IL Dimitrov
Journal: Crystal Growth & Design, 11 (1), 196–202 (2011)
Citations: 56
DOI: Link
Summary: Analyzes insulin crystallization kinetics to determine the energy barrier and size of critical nuclei using experimental and theoretical models.

📌 6. Enhancement and Suppression of Protein Crystal Nucleation Due to Electrically Driven Convection

Authors: A Penkova, O Gliko, IL Dimitrov, FV Hodjaoglu, CN Nanev, PG Vekilov
Journal: Journal of Crystal Growth, 275 (1–2), e1527–e1532 (2005)
Citations: 56
DOI: Link
Summary: Demonstrates how convection currents caused by electric fields influence nucleation via spatial inhomogeneities of supersaturation.

📌 7. On the Slow Kinetics of Protein Crystallization

Author: CN Nanev
Journal: Crystal Growth & Design, 7 (8), 1533–1540 (2007)
Citations: 50
DOI: Link
Summary: Proposes that kinetic barriers and specific protein interactions cause delays in nucleation, explaining difficulties in crystallizing many proteins.

📌 8. Theory of Nucleation

Author: CN Nanev
In: Handbook of Crystal Growth (Second Ed.), Ed. Nishinaga T., Vol. 1, 315–358 (2015)
Citations: 47
Summary: A comprehensive chapter covering classical and non-classical nucleation theories, including the effect of impurities and solution dynamics.

📌 9. Heterogeneous Nucleation of Hen‐Egg‐White Lysozyme—Molecular Approach

Authors: CN Nanev, D Tsekova
Journal: Crystal Research and Technology, 35 (8), 949–956 (2000)
Citations: 47
DOI: Link
Summary: A closer look at lysozyme-substrate interaction, proposing a molecular-level interpretation of heterogeneous nucleation.

📌 10. Protein Crystal Nucleation: Recent Notions

Author: CN Nanev
Journal: Crystal Research and Technology, 42 (8), 817–825 (2007)
Citations: 44
DOI: Link
Summary: Reviews advances in understanding protein crystal nucleation, contrasting protein-specific behavior with small-molecule crystallization.

Conclusion

Prof. Christo N. Nanev is an outstanding candidate for the Best Researcher Award. His decades-long scientific leadership, broad interdisciplinary contributions, and international recognition exemplify the essence of the award. While additional emphasis on current collaborative initiatives would enhance his profile, his longstanding impact, innovation, and dedication to science strongly support his nomination.

Qibin Liao | Immunology | Best Researcher Award

Posted on 07/04/202507/04/2025 by sciencefather

Dr. Qibin Liao | Immunology | Best Researcher Award

Assistant Researcher, at Shenzhen Third People’s Hospital, China.

Dr. Qibin Liao (b. February 1991 🇨🇳) is a leading early-career biomedical researcher specializing in cellular immunotherapy for infections and malignancies. Currently an Assistant Researcher at Shenzhen Third People’s Hospital, affiliated with the Southern University of Science and Technology, he focuses on the development of next-generation CAR-T cell therapies. His pioneering work includes genetically engineered T-cell technologies, including multifunctional CAR-T cells for HIV-1, and novel systems for solid tumors that improve safety and efficacy. Dr. Liao’s contributions have been widely recognized in high-impact journals such as EMBO Molecular Medicine, Biomedicines, and Cell Discovery. 🧪🔬 His research continues to push the boundaries of precision immunotherapy, bridging basic science and clinical application. He has also been awarded substantial national-level research funding and plays critical roles in multiple R&D programs. Through innovative designs and clinical translation, he is reshaping the future of personalized medicine and cancer treatment. 🌍💉

Professional Profile

🎓 Education

Dr. Qibin Liao began his academic journey at Southern Medical University where he earned a Bachelor of Medicine in Preventive Medicine (2010–2015). His strong foundation in public health and disease prevention laid the groundwork for his later focus on translational immunotherapy. 🚑🧠 He further advanced his training by pursuing a Ph.D. in Medical Systems Biology at Fudan University (2015–2021), one of China’s top-tier research institutions. Here, he honed his expertise in systems-level analysis and experimental techniques related to T-cell engineering and immunological signaling. His doctoral research contributed to the development of hypoxia-inducible CAR-T systems—a novel approach to improve safety and specificity in cancer therapy. 🎓💉 His interdisciplinary education spanning clinical medicine, biology, and biotechnology enables him to approach complex immunological problems with a holistic and systems-oriented mindset. This strong academic foundation underpins his contributions to advanced biomedical innovations.

💼 Professional Experience

Since October 2021, Dr. Liao has served as an Assistant Researcher at Shenzhen Third People’s Hospital, the Second Affiliated Hospital of Southern University of Science and Technology. 🏥 He is part of an elite biomedical team addressing viral infections, immune therapies, and tumor immunology. His role includes designing synthetic CAR-T constructs, leading clinical translational research, and supervising junior researchers in immunotherapy development. 💡 Before this, his graduate training involved active participation in interdisciplinary immunology and molecular biology labs at Fudan University, where he collaborated on multiple clinical and preclinical studies. His career is marked by a strategic blend of basic science and applied therapeutic innovation. Dr. Liao also serves as Principal Investigator (PI) and co-leader in several national programs funded by the National Natural Science Foundation of China and National Key R&D Program, demonstrating both scientific leadership and administrative excellence. 🧪📊

🔬 Research Interests

Dr. Liao’s research centers on cellular immunotherapy, particularly CAR-T cell technology tailored for HIV-1 and solid tumors. 💉 His key interest lies in genetic engineering of T cells to enhance therapeutic performance while minimizing toxicity. He has pioneered techniques such as the hypoxia-inducible CAR-T (HiCAR) system and PD-L1 chimeric costimulatory receptors, designed to address safety challenges in treating solid malignancies. 🧠 His research also extends to multifunctional CAR-T designs with dual antiviral and antitumor capabilities, applied in phase I clinical studies. Dr. Liao is passionate about immune microenvironment modulation, tumor-selective antigen targeting, and developing biomarker-based predictive tools for personalized therapy outcomes. 🧬 His projects integrate synthetic biology, translational immunology, and clinical oncology, making his research deeply impactful for both infectious diseases and cancer immunotherapy. His vision is to bring precision immune-engineering tools from bench to bedside. 🧑‍🔬🦠

🏆 Awards

🔹 Best Researcher Award Nomination (2025) – Selected for publication in Biomedicines (2025) for innovative CAR-T therapy targeting AXL in solid tumors.
🔹 National Natural Science Foundation of China (NSFC) – Youth Science Fund Grant (¥300,000, 2025–2027).
🔹 National Key R&D Program Grants – Totaling ¥1,125,000 as PI or task leader across two major national projects in HIV and stem cell therapy (2022–2027).
🔹 Corresponding or co-first author in top-tier journals including Cell Discovery, Journal of Advanced Research, and Biomarker Research.
🔹 Invited to multiple academic symposia and recognized for contributions to translational immunotherapy and cellular engineering.
These accolades reflect his innovative thinking, scientific rigor, and clinical impact. 🥇📚 His work continues to be spotlighted across China’s biomedical innovation ecosystem.

📚 Top Noted Publications

Dr. Liao has authored/co-authored several impactful publications. Highlights:

1. Novel mRNA-Engineered Fully Human CAR-T Cells Targeting AXL in Solid Tumors

Journal: Biomedicines
Year: 2025
Cited by: 4
Summary:

Introduces an mRNA-engineered CAR-T cell targeting AXL, a receptor overexpressed in many solid tumors.
Uses a fully human scFv to reduce immunogenicity.
Demonstrates promising anti-tumor effects in preclinical solid tumor models, with transient CAR expression for improved safety.

2. Safe CAR-T: Shedding Light on CAR-Related T-cell Malignancies

Journal: EMBO Molecular Medicine
Year: 2025
Cited by: 7
Summary:

Addresses rare but serious cases of CAR-T-cell derived T-cell malignancies.
Explores the integration of CAR constructs into oncogenes as a potential risk.
Discusses safer vector systems and genomic insertion site monitoring.

3. Efficacy and Safety of M10 CAR-T Cells in HIV-1-Infected Patients

Journal: Cell Discovery
Year: 2024
Cited by: 18
Summary:

Describes M10 CAR-T cells engineered to target HIV-1-infected cells.
First-in-human data showed viral suppression and CD4+ T-cell recovery.
Provides early evidence for CAR-T application in chronic viral infections.

4. Biomarkers for Predicting CAR-T Efficacy and Detection Methods

Journal: iLABMED
Year: 2024
Cited by: 6
Summary:

Reviews current predictive biomarkers (e.g., tumor burden, cytokine profiles, T-cell exhaustion markers).
Discusses liquid biopsy, single-cell RNA-seq, and digital PCR as detection methods.
Emphasizes personalized CAR-T strategies using biomarker profiling.

5. Mouse Model for Evaluating CAR-T On-Target Toxicity

Journal: Journal of Advanced Research
Year: 2023
Cited by: 11
Summary:

Presents a novel humanized mouse model to assess on-target/off-tumor toxicity of CAR-T cells.
Demonstrates the importance of tissue-specific antigen expression in predicting adverse effects.
Tool for preclinical safety validation.

6. Hypoxia-Inducible CAR-T Cells (HiTA System)

Journal: Journal for ImmunoTherapy of Cancer
Year: 2021
Cited by: 24
Summary:

Introduces a hypoxia-inducible switch to activate CAR-T cells only in low oxygen environments typical of solid tumors.
Reduces systemic toxicity while maintaining anti-tumor efficacy.
Demonstrates improved safety in vivo with retained tumor-killing activity.

7. PD-L1 Chimeric Receptor Improves Efficacy in Solid Tumors

Journal: Biomarker Research
Year: 2020
Cited by: 27
Summary:

Describes a chimeric receptor targeting PD-L1, converting immunosuppressive signals into activating signals.
Enhances CAR-T function in immunosuppressive microenvironments.
Synergistic potential with checkpoint inhibitors.

8. HiCAR for Selective Tumor Killing

Journal: Biomarker Research
Year: 2020
Cited by: 21
Summary:

Describes HiCAR, a system integrating tumor-specific antigens and environmental cues for precise activation.
Uses dual-input logic for increased specificity and reduced toxicity.
Aimed at improving solid tumor selectivity of CAR-T therapies.

Conclusion

Dr. Qibin Liao is highly suitable for the Best Researcher Award. His work on CAR-T innovations for both cancer and HIV is pioneering, impactful, and clinically relevant. The blend of scientific innovation, clinical translation, and strong funding/publication record positions him among the top emerging researchers in biomedical science in China.

ALI MEKKI | Microbiology | Excellence in Research

Posted on 07/04/202507/04/2025 by sciencefather

Prof. Dr. ALI MEKKI | Microbiology | Excellence in Research

Full Professor/Senior Researcher,at Sfax University, Tunisia.

Dr. Ali Mekki is a Full Professor and Senior Researcher specializing in Biological Engineering and Environmental Bioprocesses. 🌱 With over two decades of academic and research experience, he is a leading figure at the Laboratory of Environmental Bioprocesses, Center of Biotechnology of Sfax (CBS), Tunisia. His work focuses on soil biochemistry, biowaste treatment, and valorization techniques that contribute to sustainable environmental management. 🌍 Dr. Mekki has authored more than 80 scientific articles and serves as a certified reviewer for over 9 international journals. He is also on the editorial board of the Journal of Biotechnology and Phytochemistry. A respected mentor and innovator, Dr. Mekki actively collaborates on multidisciplinary projects addressing ecological resilience and agricultural biotechnology.

Professional Profile

🎓 Education

Dr. Ali Mekki’s academic journey is rooted in biological and environmental sciences. 📚 He earned his Doctorate (Ph.D.) in Biological Engineering, specializing in Soil Biochemistry and Environmental Bioprocesses. His postgraduate education equipped him with deep expertise in biotechnological applications, waste valorization, and sustainable soil management. 🌾 Over the years, Dr. Mekki has pursued advanced training in biowaste transformation technologies, environmental risk assessment, and eco-toxicological evaluation. His academic foundation laid the groundwork for a prolific career that bridges scientific innovation with real-world environmental solutions. 💡 Through continuous learning and international collaboration, he has contributed to developing educational frameworks that enhance student engagement in environmental research and sustainable agriculture.

👨‍🏫 Experience

Dr. Mekki boasts over 20 years of teaching and research experience at leading Tunisian universities. 🏛️ As a Full Professor at CBS Tunisia, he mentors graduate and doctoral students in biological engineering and bioprocess design. He has led several multidisciplinary research projects aimed at optimizing biowaste valorization systems, including anaerobic digestion, composting, and phyto-remediation. 🔬 Beyond academia, Dr. Mekki has worked closely with governmental and environmental organizations to implement green technologies for soil remediation and organic waste recycling. His collaborative approach extends to supervising international research partnerships and participating in capacity-building programs. 🤝 He regularly contributes to curriculum development, academic policy planning, and scientific dissemination.

🔬 Research Interests

Dr. Ali Mekki’s research is anchored in environmental biotechnology, with a focus on:

🌿 Biowaste treatment & valorization
🧪 Soil biochemistry and microbial dynamics
🌾 Eco-friendly bioprocesses for waste recycling
💧 Pollutant biodegradation and soil health restoration
He explores innovative methods to transform agricultural and industrial waste into valuable bio-resources, enhancing environmental sustainability. ♻️ His work on soil enzymatic activities, microbial community structure, and biodegradability assessment has earned recognition for offering eco-efficient solutions. Dr. Mekki is also deeply invested in studying bio-indicators of soil health under organic waste amendments and developing technologies for improving soil fertility and carbon sequestration. 🌍

🏅 Awards

Dr. Mekki has received numerous honors for his outstanding contributions to environmental science and biotechnology. 🏆 He has been nominated for Best Researcher in Environmental Bioprocesses multiple times and has earned recognition from national and international agencies for innovation in biowaste valorization. His dedication to academic excellence has earned him research grants, conference awards, and editorial distinctions. 📜 Additionally, he has been honored for his mentorship of young researchers and his pioneering work on sustainable soil technologies. As a respected reviewer and editorial board member, he continues to shape scientific literature and uphold high standards in peer review. ✨

📚Top Noted Publications

Dr. Mekki has authored over 80 peer-reviewed articles in journals such as Waste Management, Ecotoxicology and Environmental Safety, and Environmental Technology. 🔗 A few selected publications include:

1. Mekki A. et al. (2022)

Title: Biodegradation of olive mill waste using fungal strains
Journal: Waste Management
Summary:
This study investigates the potential of specific fungal strains for the biodegradation of olive mill waste (OMW), which is known for its high phytotoxicity and environmental burden. The researchers isolated and screened fungi for their ability to break down organic matter and reduce the toxicity of OMW. Enzymatic activity (like laccase and peroxidase) and the breakdown of phenolic compounds were central indicators of effectiveness.

Key Points:

Several fungal strains (e.g., Aspergillus, Penicillium, Trichoderma) showed significant degradation potential.
OMW treated with fungi showed reduced toxicity and better suitability for land application.
The study supports the integration of fungal treatment in waste valorization processes.

Citations: 18 (as of now)

2. Mekki A. et al. (2021)

Title: Soil enzymatic activities under compost application
Journal: Ecotoxicology and Environmental Safety
Summary:
This paper explores the impact of compost applications on soil health, particularly focusing on enzymatic activities which serve as bioindicators of microbial functioning. The study assessed the application of organic compost derived from agro-waste and its effect on enzymes like dehydrogenase, phosphatase, and urease.

Key Points:

Compost improved soil microbial activity and nutrient cycling.
Enzymatic activities were significantly higher in amended soils compared to controls.
Highlights compost’s role in improving soil quality while reducing dependence on chemical fertilizers.

Citations: 24

3. Mekki A. et al. (2019)

Title: Valorization of agricultural waste: A review
Journal: Environmental Technology
Summary:
A comprehensive review summarizing current methods for the valorization of agricultural waste, including composting, anaerobic digestion, pyrolysis, and the use of microbial treatments. It emphasizes the environmental and economic benefits of turning waste into biofertilizers, biofuels, and bioplastics.

Key Points:

Focus on circular economy approaches in agro-waste management.
Evaluation of biological, chemical, and thermal conversion techniques.
Discussion on policy implications and future research directions.

Citations: 45

Conclusion

Dr. Ali Mekki is a highly suitable candidate for an Excellence in Research award. His long-standing academic tenure, robust publication record, and recognized expertise in bioprocessing and environmental biotechnology form a solid foundation of scholarly excellence. To further elevate his candidacy, a clearer demonstration of global impact, innovation, and mentorship outcomes is recommended.

Muhammad Abubakar Siddique | Microbiology | Best Researcher Award

Posted on 03/04/202503/04/2025 by sciencefather

Dr. Muhammad Abubakar Siddique | Microbiology | Best Researcher Award

Postdoctoral Researcher, at Zhejiang University, China.

👩‍🎓 Dr. M. Abubakar Siddique is a distinguished microbiologist specializing in genomic epidemiology and molecular microbiology. Currently a Postdoctoral Researcher at Zhejiang University, China, he has made significant contributions to understanding antibiotic resistance and microbial genomics. His expertise spans whole-genome sequencing, bioinformatics, and microbial resistance mechanisms. With a focus on zoonotic foodborne pathogens, Dr. Siddique investigates antimicrobial resistance in poultry and its impact on public health. He has authored numerous high-impact publications and actively collaborates on international research projects.

Professional Profile

Education 🎓

Dr. Siddique holds a PhD in Applied Biosciences (Microbiology) from the National University of Sciences and Technology (NUST), Islamabad, Pakistan. His doctoral research, conducted in collaboration with Penn State University, focused on multidrug-resistant Salmonella enterica and probiotic-based interventions. He also earned an MPhil in Microbiology and a Doctor of Veterinary Medicine (DVM) from the University of Agriculture Faisalabad. His academic journey includes specialized training in whole-genome sequencing and antimicrobial resistance surveillance from Denmark’s Technical University.

Professional Experience 💼

Dr. Siddique is currently a Postdoctoral Researcher at Zhejiang University, China. Previously, he served as a Research Assistant at NARC, Islamabad, working on agricultural breeding innovations. He also lectured at NUST Islamabad and worked as a Veterinarian in ASAB’s Lab Animal House. His industry experience includes managing poultry farms, emphasizing his practical expertise in microbiology and veterinary sciences.

Research Interests 🌍

Dr. Siddique’s research integrates bioinformatics, comparative genomics, and molecular microbiology to study antibiotic resistance at the animal-human-environment interface. His work focuses on understanding antimicrobial resistance in zoonotic pathogens, particularly non-typhoidal Salmonella, and exploring probiotics as alternatives to antibiotics in poultry. His research also extends to the gut microbiome’s role in health and disease, employing advanced genome sequencing techniques for bacterial characterization.

Awards & Recognitions 🏆

Dr. Siddique has received multiple awards for his contributions to microbiology and public health. He has been honored with research grants and travel awards for international conferences. His work has been recognized by esteemed scientific organizations for its impact on antimicrobial resistance and food safety. He has also completed prestigious training programs on metagenomics and AMR diagnostics at global institutions.

Top Noted Publications 📖

Dr. Siddique has published extensively in high-impact journals. Some of his notable works include:

Genomic Analysis and Resistome Profiling of Multidrug-Resistant Salmonella enterica – One Health (2025) [Cited by: 5]

Authors: Not specified in the provided information.

Journal: One Health

Publication Year: 2025

Summary: This study focuses on the genomic characteristics and antibiotic resistance profiles of multidrug-resistant Salmonella enterica strains, emphasizing the implications for public health and the importance of a One Health approach.

Link: Not provided.X-MOL
Global Epidemiology and Health Risks of Bacillus cereus Infections: Special Focus on Infant Foods – Food Research International (2025) [Cited by: 3]

Authors: Na Li, Abubakar Siddique, Ningjun Liu, Lin Teng, Abdelaziz Ed-Dra, Min Yue, Yan LiMDPI+2X-MOL+2PMC+2

Journal: Food Research International

Publication Year: 2025

Summary: This paper provides an overview of the worldwide distribution and health risks associated with Bacillus cereus infections, with a particular emphasis on infant foods. The study highlights the need for improved food safety measures to protect vulnerable populations.

Link: Global Epidemiology and Health Risks of Bacillus cereus InfectionsX-MOL
Isolation, Characterization, and Genome Sequencing Analysis of a Novel Phage HBW-1 of Salmonella – Microbial Pathogenesis (2025) [Cited by: 2]

Authors: Not specified in the provided information.

Journal: Microbial Pathogenesis

Publication Year: 2025PubMed

Summary: This research reports the isolation and characterization of a new bacteriophage, HBW-1, which exhibits lytic activity against Salmonella strains. The study suggests its potential as an alternative to antibiotics in controlling Salmonella infections.

Link: Isolation and Genome Sequencing Analysis of a Novel Phage HBW-1 of Salmonella
The Evolution of Vaccines Development across Salmonella Serovars among Animal Hosts: A Systematic Review – Vaccines (2024) [Cited by: 4]

Authors: Abubakar Siddique, Zining Wang, Haiyang Zhou, Linlin Huang, Chenghao Jia, Baikui Wang, Abdelaziz Ed-Dra, Lin Teng, Yan Li, Min YueX-MOL+2MDPI+2PMC+2

Journal: VaccinesPMC

Publication Year: 2024MDPI+1X-MOL+1

Summary: This systematic review examines the progression of vaccine development targeting various Salmonella serovars in animal hosts. It discusses the efficacy of different vaccine strategies and highlights the need for innovative approaches in combating Salmonella infections.

Link: The Evolution of Vaccines Development across Salmonella Serovars among Animal Hosts: A Systematic ReviewMDPI+1PMC+1
Impact of COVID-19 on Zoonotic Salmonella Prevalence – hLife (2024) [Cited by: 6]

Authors: Not specified in the provided information.

Journal: hLife

Publication Year: 2024

Summary: This study investigates how the COVID-19 pandemic has influenced the prevalence of zoonotic Salmonella infections, considering factors such as changes in human behavior, animal interactions, and public health policies.

Link: Not provided.

Conclusion

Dr. M. Abubakar Siddique is a strong candidate for the Best Researcher Award due to his cutting-edge contributions to antimicrobial resistance, foodborne pathogens, and comparative genomics. His international collaborations, diverse technical expertise, and high-impact publications make him a standout researcher in microbiology and epidemiology.

Mansour Sedighi | Microbiology | Best Researcher Award

Posted on 01/04/202501/04/2025 by sciencefather

Assist. Prof. Dr. Mansour Sedighi | Microbiology | Best Researcher Award

Author, at Kurdistan University of Medical Sciences, Iran.

✨ Dr. Mansour Sedighi is a distinguished microbiologist specializing in medical bacteriology. With a Ph.D. from Iran University of Medical Sciences, his research focuses on antimicrobial resistance, foodborne pathogens, and molecular diagnostics. He possesses extensive experience in diagnostic microbiology, bacterial DNA sequencing, and immunoassay development. Dr. Sedighi has contributed significantly to understanding drug-resistant bacteria, with numerous publications in reputed journals. His expertise spans advanced molecular techniques, including PCR, qPCR, and various chromatographic methods. Passionate about microbial research, he continues to make significant strides in infectious disease control and bacterial genomics.

Professional Profile

Education 🎓

Dr. Sedighi completed his Ph.D. in Medical Bacteriology from Iran University of Medical Sciences in 2017. Prior to that, he earned his M.Sc. in Medical Microbiology from Isfahan University of Medical Sciences in 2014. His academic journey began with a B.Sc. in Veterinary Laboratory Sciences from the University of Hamadan in 2011, followed by an Associate degree in Veterinary from the University of Zabol in 2009. His diverse educational background has provided him with a strong foundation in microbiology, molecular biology, and infectious disease research.

Experience 👨‍🎓

Dr. Sedighi has extensive experience in diagnostic and clinical microbiology, with expertise in antimicrobial resistance and bacterial genomics. He has worked with various molecular biology techniques, including PCR, qPCR, sequencing, and electrophoresis. His technical proficiency also includes protein purification, enterotoxin production, and chromatographic techniques like HPLC and FPLC. Dr. Sedighi has played a crucial role in developing immunoassays such as ELISA and RIA. His research has significantly contributed to understanding and combating bacterial resistance in clinical settings, making him a respected expert in the field.

Research Interest 🔬

Dr. Sedighi’s research focuses on antimicrobial resistance mechanisms, foodborne pathogens, and molecular diagnostics. He is particularly interested in developing rapid diagnostic techniques for drug-resistant bacteria and investigating new antimicrobial strategies. His work on metallo-β-lactamases in Pseudomonas aeruginosa has been instrumental in understanding resistance patterns in clinical isolates. Additionally, he explores nutritional studies and defined media development for bacterial growth and toxin production. His research aims to improve public health by addressing global microbial threats.

Awards 🏆

Dr. Sedighi has received numerous accolades for his contributions to microbiology and infectious disease research. His work on antimicrobial resistance has been recognized in both national and international scientific communities. His dedication to bacterial genomics and innovative diagnostic methods has earned him research grants and awards from esteemed medical and scientific organizations. He continues to push the boundaries of microbiological research with his groundbreaking studies.

Top Noted Publications 📚

Dr. Sedighi has authored numerous research papers in high-impact journals. His work spans antimicrobial resistance, bacterial genomics, and molecular diagnostics. Here are some notable publications:

Identification of Metallo-β-Lactamase and Drug Resistance Pattern of Pseudomonas aeruginosa Strains
- Journal: Global Journal of Medicine Researches and Studies
- Year: 2014
- Citations: Cited by multiple studies
- Focus: Investigates the presence of metallo-β-lactamases in Pseudomonas aeruginosa and their antimicrobial resistance patterns.
Antimicrobial Resistant Pattern of Pseudomonas aeruginosa Strains
- Journal: Global Journal of Medicine Researches and Studies
- Year: 2014
- Citations: Widely referenced
- Focus: Examines resistance patterns of Pseudomonas aeruginosa against different antimicrobial agents.
Identification of Non-Tuberculosis Mycobacteria by PCR-Restriction Enzyme Analysis
- Journal: Journal of Isfahan Medical School
- Year: 2014
- Focus: Uses PCR-Restriction Enzyme Analysis for detecting non-tuberculous mycobacteria.
Prevalence and Antibacterial Resistance of Coagulase Negative Staphylococci
- Journal: Journal of Isfahan Medical School
- Year: 2014
- Focus: Studies the occurrence and resistance patterns of coagulase-negative Staphylococci.
Molecular Detection of blaSPM-1 Gene in Pseudomonas aeruginosa
- Journal: Biological Journal of Microorganism
- Year: 2015
- Focus: Identifies the blaSPM-1 resistance gene in Pseudomonas aeruginosa strains.
Serological Diagnosis of Helicobacter pylori Infection
- Journal: Archives of Clinical Infectious Diseases (Arch Clin Infect Dis)
- Year: 2015
- Focus: Investigates serological methods for diagnosing Helicobacter pylori infection.

Conclusion

Dr. Mansour Sedighi is a highly qualified researcher in medical bacteriology with extensive publications and technical expertise. His work on antimicrobial resistance and clinical microbiology makes a significant contribution to the field. While he is a strong candidate for the Best Researcher Award, further international collaborations, research diversification, and leadership roles could further solidify his candidacy for top-tier recognition.

Nadia Jaidane | Microbiology | Women Researcher Award

Posted on 01/04/202501/04/2025 by sciencefather

Dr. Nadia Jaidane | Microbiology | Women Researcher Award

Postdoctoral researcher, at Faculty of medecine Sousse, Tunisia.

🌟 Dr. Nadia Jaidane is a distinguished microbiologist specializing in pharmaceutical sciences. Born on September 17, 1976, in Tunisia, she has made significant contributions to the field of clinical microbiology and bacterial resistance research. With over two decades of experience, she is currently a Professor of Paramedical Education at the Higher School of Health Sciences and Techniques of Monastir. Her research focuses on antimicrobial resistance, hospital hygiene, and infectious diseases, contributing to numerous scientific publications and international collaborations. She actively participates in scientific congresses and professional organizations, reinforcing her expertise in the field.

Professional Profile

Education

🎓 Dr. Jaidane holds a Ph.D. in Pharmaceutical Sciences, specializing in Microbiology, awarded with “Very Honourable Distinction” from the Faculty of Pharmacy of Monastir, Tunisia, in collaboration with the University of Paris-Sud. She also holds multiple master’s degrees in hospital hygiene, food quality and bioprocesses, and life and earth sciences, all obtained with honors. Additionally, she has a Graduate Diploma in Medical Biology and a Complementary Diploma in Medical Pedagogy from Faculty of Medicine Ibn El Jazzar – Sousse. Her diverse academic background equips her with expertise in microbiology, medical education, and quality management in healthcare.

Experience

💼 Dr. Jaidane has held several key roles in academia and healthcare. Since 2013, she has been a Professor of Paramedical Education, training students in medical biology. Previously, she served as a Hygienist Technician at the Department of Prevention and Security of Care at Sahloul University Hospital, where she contributed to infection control and hospital hygiene. She also worked as an Epidemiologist Technician and a Sleep/Neurodiagnostic Technician, demonstrating her versatility in medical sciences. Her extensive experience bridges research, clinical practice, and education in microbiology and public health.

Research Interests

📚 Dr. Jaidane’s research interests focus on antimicrobial resistance, infectious diseases, and hospital hygiene. She has conducted genomic studies on resistant bacterial strains, particularly Klebsiella pneumoniae and Acinetobacter baumannii, contributing to the understanding of bacterial resistance mechanisms. Her work also explores epidemiological trends in nosocomial infections and antibiotic consumption patterns in healthcare settings. Through her research, she aims to develop strategies for controlling and preventing bacterial infections in hospitals, thereby improving patient safety and public health outcomes.

Awards & Recognitions

🏆 Dr. Jaidane has received multiple honors throughout her career. She earned “Very Honourable Distinction” for her Ph.D. and “Honors” in all her master’s degrees. She has been an active member of scientific congresses, contributing to the advancement of microbiology and hospital hygiene. Additionally, she has played a pivotal role in several epidemiological studies on infection control, receiving recognition for her contributions to healthcare safety and antimicrobial resistance research.

Top Noted Publications

📚 Dr. Jaidane has authored multiple peer-reviewed publications in high-impact journals, including:

Genomic analysis of in vivo acquired resistance to colistin and rifampin in Acinetobacter baumannii
- Journal: International Journal of Antimicrobial Agents, 2018
- Citations: 50+
- Summary: This study investigates genetic mechanisms underlying colistin and rifampin resistance in A. baumannii through whole-genome sequencing. It identifies mutations contributing to resistance development during treatment.
Genomic Insights into Colistin-Resistant Klebsiella pneumoniae
- Journal: Antimicrobial Agents and Chemotherapy, 2018
- Citations: 40+
- Summary: This paper explores genetic adaptations in K. pneumoniae strains resistant to colistin, revealing mutations in genes associated with lipid A modification and efflux pumps.
Whole genome sequencing of NDM-1-producing ST85 Acinetobacter baumannii
- Journal: International Journal of Antimicrobial Agents, 2018
- Citations: 35+
- Summary: The study characterizes A. baumannii ST85 strains harboring the NDM-1 carbapenemase gene, highlighting their genomic features and resistance determinants.
Temporal Variation in Antibiotic Resistance of Acinetobacter baumannii
- Journal: The Open Microbiology Journal, 2019
- Citations: 20+
- Summary: This research analyzes the changing patterns of antibiotic resistance in A. baumannii over time, providing insights into epidemiological trends and resistance evolution.
Epidemiology of resistance and phenotypic characterization of carbapenem resistance
- Journal: African Health Sciences, 2019
- Citations: 15+
- Summary: The study describes the epidemiology and resistance mechanisms of carbapenem-resistant bacteria, emphasizing phenotypic and molecular characterization.
Ten golden rules for optimal antibiotic use in hospital settings
- Journal: World Journal of Emergency Surgery, 2023
- Citations: 10+
- Summary: This paper outlines key principles for antimicrobial stewardship in hospitals, aiming to reduce resistance development and improve patient outcomes.

Conclusion

Dr. Nadia Jaidane is a highly qualified candidate with a strong research portfolio in microbiology and antimicrobial resistance. Her extensive academic background, impactful publications, and active engagement in the scientific community make her a strong contender. To maximize her chances, demonstrating leadership in grant-funded projects, winning more international awards, and emphasizing research impact on public health policy would further strengthen her application.

Jordan Leal | Quality Improvement | Best Researcher Award

Posted on 27/03/202527/03/2025 by sciencefather

Dr. Jordan Leal | Quality Improvement | Best Researcher Award

Nurse Practitioner, at University of Kansas Cancer Center, United States.

🌟 Jordan Leal, DNP, AGNP-C, BMTCN, is a dedicated board-certified Nurse Practitioner specializing in Hematologic Malignancies and Cellular Therapeutics. Since 2014, he has been an integral part of the Blood and Marrow Transplantation Program at The University of Kansas Health System (TUKHS). With extensive experience in performing complex clinical procedures such as bone marrow aspirates, biopsies, lumbar punctures, and intrathecal chemotherapy administration, Jordan is a trusted healthcare professional. Beyond his clinical expertise, he actively engages in professional development, contributing to various committees and attending key conferences, including ASTCT Tandem Meetings. His leadership as BMT APP Coordinator at the University of Kansas Cancer Center highlights his commitment to advancing patient care and medical education.

Professional Profile

Education 🎓

Jordan Leal holds a Doctor of Nursing Practice (DNP) from the University of Kansas School of Nursing, earned in December 2023. His DNP project focused on “Implementing a Standardized Workflow for Early Detection of Steroid-Induced Hyperglycemia: A Quality Improvement Project.” He also obtained a Master of Science in Nursing (MSN) in Adult-Gerontology in May 2014 and a Bachelor of Science in Nursing (BSN) in May 2009, both from the University of Kansas. Jordan’s academic journey reflects his strong foundation in nursing education and his commitment to improving healthcare practices through research and innovation.

Experience 💼

Jordan Leal has been serving as the BMT APP Coordinator at the University of Kansas Cancer Center since 2023, overseeing the Blood and Marrow Transplant Program. Prior to this role, he worked as a Nurse Practitioner in the same program from 2014 to the present, providing expert care in transplantation and cellular therapy. His journey began as a Registered Nurse in the Medical/Transplant Intensive Care Unit at the University of Kansas Health System from 2009 to 2014. His extensive experience across various nursing roles has solidified his expertise in critical care, transplant medicine, and patient-centered clinical practice.

Research Interest 🔬

Jordan’s research focuses on improving outcomes for patients undergoing hematologic malignancy treatments and bone marrow transplantation. His work includes investigating steroid-induced hyperglycemia management in transplant recipients, innovative cellular therapies, and optimizing workflows for early detection of complications. He actively collaborates on clinical studies to enhance treatment protocols, ensuring better patient care and safety. His research contributions are evident in his publications, where he explores immune effector cell-associated encephalopathy and diabetes management in post-transplant settings.

Awards 🏆

Jordan Leal has received multiple accolades for his contributions to nursing and research. In 2024, he secured 3rd place in the APP Best Abstracts competition. He was nominated for the prestigious APP of the Year Award in 2023, recognizing his excellence in clinical practice. He also received the School of Nursing Spring 2023 Scholarship Award for outstanding performance in nursing education. In 2022, he was awarded the KUMC Auxiliary Grant to support patients with steroid-induced hyperglycemia. His early achievements include the Dean’s Award in 2009 for outstanding service to the School of Nursing.

Top Noted Publications 📚

Development of a Modified Immune Effector Cell-Associated Encephalopathy Score for the Developmentally Delayed Patient
- Authors: Stark, K., Leal, J., Rodriguez, L., Mahmoudjafari, Z., & Singh, A. K.
- Publication Year: 2025
- Journal: Transplantation and Cellular TherapyPubMed+5Lippincott Journals+5PubMed+5
- Volume and Issue: 31(2), S453
- Summary: This study addresses the challenge of assessing neurotoxicity in developmentally delayed patients undergoing immune effector cell therapies. Recognizing the absence of suitable assessment tools, the authors developed a modified Immune Effector Cell-Associated Encephalopathy (ICE) score tailored for this patient population. The tool employs a 10-point scale evaluating the patient’s ability to identify time and location through image selection, follow commands, write their name, and assesses behaviors such as underactivity, restlessness, and inconsolability. It was successfully implemented in a nonverbal adult with developmental delays receiving CAR-T treatment for acute lymphoblastic leukemia, demonstrating its potential utility. The authors suggest further validation with a larger patient population to establish its efficacy. ASTCT Journal
Implementing a Standardized Workflow for Early Detection of Steroid-Induced Hyperglycemia in Allogeneic Stem Cell Transplant Recipients: A Quality Improvement Project
- Authors: Leal, J., Wesson, W., Rodriguez, L., Gray, J., Bosak, K., McGuirk, J., & Grdinovac, K.
- Publication Year: 2024
- Journal: Transplantation ReportsLippincott Journals
- Article Number: 100162
- Summary: Steroid-induced hyperglycemia (SIH) is associated with increased non-relapse mortality in stem cell transplant recipients. This quality improvement initiative aimed to decrease the median time to identification and treatment of SIH in patients on glucocorticoids for graft-versus-host disease (GVHD). Patients were instructed to monitor their blood sugar 1-2 hours after their largest meal for 14 days. Compared to a retrospective control group, the intervention group had a significantly shorter median time to identification of SIH (1.5 days vs. 7 days) and initiation of insulin treatment (2 days vs. 10 days). The study concluded that daily postprandial blood sugar monitoring facilitates earlier detection and treatment of SIH in this patient population. ASTCT Journal+1Directory of Open Access Journals – DOAJ+1
152-LB: Implementing a Pilot Clinic for Steroid-Induced Hyperglycemia in Graft vs. Host Disease
- Authors: Pham, D., Grdinovac, K., Leal, J., Rodriguez, L., Salva, A., Wesson, W., & McGuirk, J.
- Publication Year: 2023
- Journal: Diabetes
- Volume: 72(Supplement_1)
- Summary: This study discusses the establishment of a pilot clinic dedicated to managing steroid-induced hyperglycemia (SIH) in patients with graft-versus-host disease (GVHD) following hematopoietic stem cell transplantation. Over 12 months, patients were referred to a diabetes-specialized physician assistant and seen at intervals based on acuity and glycemic control. The intervention led to a significant reduction in median highest glucose levels within the first 3 months (230 mg/dL) compared to 3-6 months (161 mg/dL). The study highlights the complexity of managing SIH and underscores the importance of a multidisciplinary approach to improve glycemic outcomes in this patient population.

Conclusion

Jordan Leal demonstrates strong qualifications for a Best Researcher Award, with significant clinical research, publications, and leadership in hematologic malignancies and cellular therapeutics. While increasing independent research funding and first-author publications could enhance the application, Jordan’s contributions to stem cell transplantation and oncology nursing are commendable and make a compelling case for recognition.

Xueyan Zhan | Biotechnology | Women Researcher Award

Posted on 26/03/202526/03/2025 by sciencefather

Assoc. Prof. Dr. Xueyan Zhan | Biotechnology | Women Researcher Award

Associate Professor, at Beijing University of Chinese Medicine, China.

Xueyan Zhan is an Associate Professor at the School of Chinese Materia Medica, Beijing University of Chinese Medicine, China. She obtained her Ph.D. in Chinese Materia Medica from Beijing University of Chinese Medicine in 2011 and has dedicated over a decade to research in traditional Chinese medicine (TCM). As a graduate supervisor, she has led groundbreaking studies on TCM preparation processes and holistic quality evaluation. With five national and provincial research projects under her leadership, she has secured three patents and published ten SCI-expanded papers. Her contributions to TCM standardization and bioactive compound utilization have earned her prestigious awards, including the First Prize of the Beijing Science and Technology Award. She actively collaborates with industries and serves on editorial boards, fostering innovation in TCM research and application.

Professional Profile